LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Videos

Why Are US Companies Stalking UK Firms?

VIDEO: One Fool puts AstraZeneca plc (LON:AZN) and InterContinental Hotels Group PLC (LON:IHG) under the spotlight.

Read more »

Company Comment

Why Are US Companies Stalking UK Firms Like AstraZeneca plc And InterContinental Hotels Group PLC?

AstraZeneca plc (LON:AZN) and Intercontinental Hotels Group PLC (LON:IHG) may be prized for their tax rates as well as their…

Read more »

Investing Articles

Why Neil Woodford Is Backing AstraZeneca plc

Bye-bye Pfizeneca; welcome back AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Could AstraZeneca plc Be Worth £98.67?

We speculate on what AstraZenenca plc (LON: AZN) shares might be worth now that the Pfizer offer is gone.

Read more »

Company Comment

AstraZeneca plc Drops 2% As Pfizer Finally Withdraws Offer

AstraZeneca plc (LON:AZN) believes it can create "significant value" for its shareholders.

Read more »

Investing Videos

Lessons From The AstraZeneca plc/Pfizer Kerfuffle

VIDEO: One Fool puts the spotlight on AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

The AstraZeneca plc Takeover Could Still Be On

Major shareholders are urging AstraZenenca plc (LON: AZN) to reconsider Pfizer's offer.

Read more »

Investing Articles

AstraZeneca plc: Is It Still A Buy Now That Pfizer Has Gone?

Should you buy what Pfizer couldn't? Harvey Jones examines the case for AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

All Is Not Lost: AstraZeneca plc Has Less Than 48hrs To Cut A Deal With Pfizer

AstraZeneca plc (LON: AZN) has until Monday to negotiate a deal with Pfizer.

Read more »

Investing Articles

AstraZeneca plc Was Right To Shun Pfizer

Pfizer's bid for AstraZeneca plc (LON: AZN) was not in the long-term interests of the business.

Read more »

Investing Articles

Who Can Pfizer Inc. Afford?

Are Bristol-Myers Squibb Co (NYSE: BMY) or Shire PLC (LON:SHP) on Pfizer Inc. (NYSE:PFE)'s shopping list?

Read more »

Investing Articles

Why Do People Care If One Company Buys Another?

Who cares if Pfizer wants to buy AstraZeneca plc (LON:AZN)? We all do, says Harvey Jones

Read more »